USS Investment Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-86,002
Closed -$2.4M 591
2022
Q4
$2.4M Buy
86,002
+4,676
+6% +$120K 0.03% 468
2022
Q3
$1.9M Buy
81,326
+4,668
+6% +$141K 0.03% 496
2022
Q2
$2.59M Sell
76,658
-39,420
-34% -$1.38M 0.03% 517
2022
Q1
$4.05M Buy
116,078
+76,658
+194% +$2.62M 0.03% 490
2021
Q4
$1.2M Hold
39,420
0.01% 675
2021
Q3
$1.29M Sell
39,420
-171,110
-81% -$5.47M 0.01% 680
2021
Q2
$6.37M Buy
+210,530
New +$6.93M 0.05% 221

Other funds holding OGN

USS Investment Management's OGN Position: Q1 2023 in Review

USS Investment Management sold out of Organon & Co (OGN) in Q1 2023, closing a stake of 86,002 shares — an estimated $2.4M sold.

USS Investment Management first reported a position in OGN in Q2 2021 and held it in 7 quarters. The position peaked at $6.37M in Q2 2021. 767 funds tracked by Wall St. Rank hold OGN as of Q1 2023.

  • USS Investment Management reported no remaining Organon & Co position as of Q1 2023 after selling out during the quarter.
  • USS Investment Management sold 86,002 Organon & Co shares in Q1 2023, an estimated $2.4M.
  • USS Investment Management first reported a position in Organon & Co in Q2 2021 and held it in 7 quarters.
  • USS Investment Management's Organon & Co position peaked at $6.37M in Q2 2021.
  • 767 funds tracked by Wall St. Rank held Organon & Co as of Q1 2023.

Based on USS Investment Management's 13F filing for Q1 2023, filed 15 May 2023.